Logo

American Heart Association

  15
  0


Final ID: Tu0043

Modeling Concurrent Metabolic Dysfunction-Associated Steatohepatitis and Atherosclerosis in Mice

Abstract Body: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent form of liver disease, affecting one-third of the global population with limited treatment available. MASLD is a spectrum of liver diseases that initiates from simple hepatic steatosis and progresses towards metabolic dysfunction-associated steatohepatitis (MASH). MASH is characterized by lobular inflammation and hepatic fibrosis, and if left untreated progresses to cirrhosis. While MASH is associated with an elevated risk of liver-related mortality, the leading cause of death in patients with MASH is atherosclerotic cardiovascular disease. Importantly, no current therapy targets both MASH and atherosclerosis simultaneously. A key challenge in developing new treatments is the lack of animal models that mimic both diseases simultaneously, especially in females. To address this challenge and to establish a useful model of concurrent MASH and atherosclerosis, we utilized both male and female Ldlr-/- mice, combined with different dietary regimens containing equal and physiologically relevant cholesterol levels. These included a Western Diet (WD), modified choline-deficient high-fat diet (mCDHFD), and modified MASH diet (mMASHD), all which were compared with a standard low-fat diet. Using a multiomics approach that integrates metabolomics, lipidomics, and transcriptomics with histopathological and biochemical analyses, we report the development of a murine model that concurrently features MASH and atherosclerosis. This model displays transcriptomic signatures comparable to those of human disease and reveals sexual dimorphism in response to different dietary regimens. Notably, we identified novel metabolites (arginine, glycine, itaconate, and sphinganine), and key genes (Trem2, Ccl2, and Cd52) implicated in both diseases. The use of this model will be instrumental in advancing our understanding of the shared pathophysiology of MASH and atherosclerosis and in facilitating the development of dual therapeutic approaches.
  • Das, Sandeep  ( LSU HEALTH, SHREVEPORT , Shreveport , Louisiana , United States )
  • Tan, Lin  ( The University of Texas MD Anderson Cancer Center, Houston, TX 77030, , Houston , Texas , United States )
  • Liu, Zhipeng  ( Purdue University , West Lafayette , Indiana , United States )
  • Kumar, Dhananjay  ( LSU HEALTH, SHREVEPORT , Shreveport , Louisiana , United States )
  • Pandey, Nilesh  ( LSU HEALTH, SHREVEPORT , SHREVEPORT , Louisiana , United States )
  • Kaur, Harpreet  ( LSU HEALTH, SHREVEPORT , Shreveport , Louisiana , United States )
  • Razani, Babak  ( University of Pittsburgh and UPMC , Pittsburgh , Pennsylvania , United States )
  • Cai, Bishuang  ( Icahn School of Medicine at Mount S , New York , New York , United States )
  • Liu, Wanqing  ( Wayne State University , Detroit , Michigan , United States )
  • Fisher, Edward  ( NYU Grossman School of Medicine , NY , New York , United States )
  • Radhakrishnan, Sridhar  ( Research Diets Inc., , New Brunswick, , New Jersey , United States )
  • Anand, Sumit  ( LSU HEALTH, SHREVEPORT , SHREVEPORT , Louisiana , United States )
  • Gottlieb, Eyal  ( University of Texas MD Anderson Cancer Center , Houston , Texas , United States )
  • Orr, Wayne  ( LSU HEALTH, SHREVEPORT , Shreveport , Louisiana , United States )
  • Dhanesha, Nirav  ( LSU HEALTH, SHREVEPORT , Shreveport , Louisiana , United States )
  • Yurdagul, Arif  ( LSU HEALTH, SHREVEPORT , Shreveport , Louisiana , United States )
  • Lorenzi, Philip  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Rom, Oren  ( LSU HEALTH, SHREVEPORT , SHREVEPORT , Louisiana , United States )
  • Mckinney, Mary  ( LSU HEALTH, SHREVEPORT , SHREVEPORT , Louisiana , United States )
  • Mahmud, Iqbal  ( The University of Texas MD Anderson Cancer Center, Houston, TX 77030, , Houston , Texas , United States )
  • Rohilla, Sumati  ( LSU HEALTH, SHREVEPORT , SHREVEPORT , Louisiana , United States )
  • Richard, Koral  ( LSU HEALTH, SHREVEPORT , SHREVEPORT , Louisiana , United States )
  • Arias Bordajandi, Fabio  ( LSU HEALTH, SHREVEPORT , Shreveport , Louisiana , United States )
  • Ghrayeb, Alia  ( LSU HEALTH, SHREVEPORT , SHREVEPORT , Louisiana , United States )
  • Wei, Bo  ( The University of Texas MD Anderson Cancer Center, Houston, TX 77030, , Houston , Texas , United States )
  • Author Disclosures:
    Sandeep Das: DO NOT have relevant financial relationships | Lin Tan: DO NOT have relevant financial relationships | zhipeng liu: No Answer | Dhananjay kumar: No Answer | Nilesh Pandey: No Answer | Harpreet Kaur: No Answer | Babak Razani: DO NOT have relevant financial relationships | Bishuang Cai: DO NOT have relevant financial relationships | Wanqing Liu: No Answer | Edward Fisher: No Answer | Sridhar Radhakrishnan: No Answer | SUMIT ANAND: DO NOT have relevant financial relationships | Eyal Gottlieb: No Answer | Wayne Orr: DO NOT have relevant financial relationships | Nirav Dhanesha: DO NOT have relevant financial relationships | Arif Yurdagul: DO NOT have relevant financial relationships | Philip Lorenzi: DO NOT have relevant financial relationships | Oren Rom: No Answer | mary McKinney: DO NOT have relevant financial relationships | Iqbal Mahmud: No Answer | Sumati Rohilla: No Answer | Koral Richard: No Answer | Fabio Arias Bordajandi: DO have relevant financial relationships ; Employee:Arias Arias Pharmacy:Past (completed) | Alia Ghrayeb: No Answer | Bo Wei: No Answer
Meeting Info:
Session Info:

01. Poster Session 1 & Reception

Tuesday, 04/22/2025 , 06:00PM - 08:00PM

Poster

More abstracts on this topic:
Inhibition of Nicotinamide N-Methyltransferase Enhances Limb Function in Experimental Peripheral Artery Disease

Dong Gengfu, Choi Jaewon, Luo Yangyi, Li Zhuoxin, Muller Diana, Li Yufen, Russel Jennifer, Yue Feng, Ryan Terence

Liver Steatosis and Liver Fibrosis Predict Major Adverse Cardiovascular Events in the CLEAR Outcomes Trial

De Jong Vivian, Grobbee Diederick, Saidi Alina, Castro Cabezas Manuel, Nissen Steven, Sasiela William, Li Na, Bloedon Leanne, Lincoff Abraham, Nicholls Stephen

More abstracts from these authors:
Hepatic Serine Hydroxymethyltransferase 2 Drives Atherosclerosis through One-Carbon Metabolic Regulation of VLDL and Ceramides

Richard Koral, Wei Bo, Mahmud Iqbal, Tan Lin, Orr Wayne, Yurdagul Arif, Mor Inbal, Lorenzi Philip, Gottlieb Eyal, Rom Oren, Ghrayeb Alia, Mckinney Mary, Finney Alexandra, Anand Sumit, Rohilla Sumati, Das Sandeep, Arias Bordajandi Fabio, Pearson-gallion Brenna

Untargeted Metabolomics Reveals the Critical Role of Dysregulated Hepatic Oxalate Metabolism in Stroke Recovery

Kaur Harpreet, Orr Wayne, Yurdagul Arif, Rom Oren, Dhanesha Nirav, Pandey Nilesh, Anand Sumit, Martinez Alexa, Rohilla Sumati, Das Sandeep, Richard Koral, Arias Bordajandi Fabio, Stokes Karen

You have to be authorized to contact abstract author. Please, Login
Not Available
OSZAR »